The use of aflibercept (Eylea) in the treatment of polypoidal choroidal vasculopathy--case report
Glasner, P.; Raczyńska, D.; Glasner, L.
Klinika Oczna 117(3): 189-192
2015
ISSN/ISBN: 0023-2157 PMID: 26999944 Document Number: 680229
The paper presents a case of a 25-year-old woman referred to the Outpatient Clinic at the Department of Ophthalmology, University Clinical Centre in Gdansk, with sudden vision impairment in her right eye. Clinical manifestation and diagnostic tests gave a basis for the preliminary diagnosis of polypoidal choroidal vasculopathy. Polypoidal choroidal vasculopathy is a type of choroidal neovascularisation, frequently confused with age-related macular degeneration. Standard treatment includes photodynamic therapy and intravitreal injections of anti-vascular endothelial growth factor agents. 2.0 miligrams of aflibercept was administered as an intravitreal injection, causing a rapid, significant improvement of visual function and proper anatomical relationships within the retina.